Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Mar 2022
Historique:
pubmed: 26 1 2021
medline: 19 3 2022
entrez: 25 1 2021
Statut: ppublish

Résumé

To develop and validate a new risk prediction model for predicting the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in Japanese adults. A total of 2,454 participants aged 40-84 years without a history of cardiovascular disease (CVD) were prospectively followed up for 24 years. An incident ASCVD event was defined as the first occurrence of coronary heart disease or atherothrombotic brain infarction. A Cox proportional hazards regression model was used to construct the prediction model. In addition, a simplified scoring system was translated from the developed prediction model. The model performance was evaluated using Harrell's C statistics, a calibration plot with the Greenwood-Nam-D'Agostino test, and a bootstrap validation procedure. During a median of a 24-year follow-up, 270 participants experienced the first ASCVD event. The predictors of the ASCVD events in the multivariable Cox model included age, sex, systolic blood pressure, diabetes, serum high-density lipoprotein cholesterol, serum low-density lipoprotein cholesterol, proteinuria, smoking habits, and regular exercise. The developed models exhibited good discrimination with negligible evidence of overfitting (Harrell's C statistics: 0.786 for the multivariable model and 0.789 for the simplified score) and good calibrations (the Greenwood-Nam-D'Agostino test: P=0.29 for the multivariable model, 0.52 for the simplified score). We constructed a risk prediction model for the development of ASCVD in Japanese adults. This prediction model exhibits great potential as a tool for predicting the risk of ASCVD in clinical practice by enabling the identification of specific risk factors for ASCVD in individual patients.

Identifiants

pubmed: 33487620
doi: 10.5551/jat.61960
pmc: PMC8894117
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-361

Références

Atherosclerosis. 2014 Apr;233(2):343-348
pubmed: 24530960
JAMA Neurol. 2018 Feb 1;75(2):203-211
pubmed: 29279888
Stroke. 2009 Feb;40(2):382-8
pubmed: 19095987
Stroke. 1990 Apr;21(4):637-76
pubmed: 2326846
Circulation. 2016 Nov 8;134(19):1430-1440
pubmed: 27682885
Arch Neurol. 1986 Jan;43(1):71-84
pubmed: 3510609
Circulation. 2013 Sep 10;128(11):1198-205
pubmed: 23902756
Stat Med. 2001 Mar 15;20(5):661-84
pubmed: 11241570
J Atheroscler Thromb. 2014;21(8):784-98
pubmed: 24671110
J Am Heart Assoc. 2017 Aug 31;6(9):
pubmed: 28860232
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Eur Heart J. 2003 Sep;24(17):1601-10
pubmed: 12964575
Circ J. 2016 May 25;80(6):1386-95
pubmed: 27087361
Circulation. 2009 Jun 23;119(24):3078-84
pubmed: 19506114
Atherosclerosis. 2018 Dec;279:38-44
pubmed: 30408715
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Stroke. 2013 May;44(5):1295-302
pubmed: 23449266
J Atheroscler Thromb. 2015;22(12):1287-304
pubmed: 26289083
BMJ. 2016 May 16;353:i2416
pubmed: 27184143
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
J Atheroscler Thromb. 2020 Nov 1;27(11):1160-1175
pubmed: 32023562
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
J Epidemiol. 2018 Nov 5;28(11):444-451
pubmed: 30298863
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
Stat Med. 2015 May 10;34(10):1659-80
pubmed: 25684707
Hypertens Res. 2009 Dec;32(12):1119-22
pubmed: 19763133
Stroke. 2012 Jul;43(7):1998-2027
pubmed: 22627990
Heart. 2014 Apr;100 Suppl 2:ii1-ii67
pubmed: 24667225
Eur Heart J. 2004 Jul;25(14):1197-207
pubmed: 15246637
J Epidemiol. 2009;19(2):94-100
pubmed: 19265268
Stroke. 2000 Nov;31(11):2616-22
pubmed: 11062284
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930
Stat Med. 2004 May 30;23(10):1631-60
pubmed: 15122742

Auteurs

Takanori Honda (T)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.

Sanmei Chen (S)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.

Jun Hata (J)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.

Daigo Yoshida (D)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.

Yoichiro Hirakawa (Y)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.

Yoshihiko Furuta (Y)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.
Department of Medical-Engineering Collaboration for Healthy Longevity, Graduate School of Medical Sciences, Kyushu University.

Mao Shibata (M)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.

Satoko Sakata (S)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.

Takanari Kitazono (T)

Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.

Toshiharu Ninomiya (T)

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH